标普道琼斯指数宣布,休伦咨询将接替Supernus Pharmaceuticals,成为标普小盘600指数成分股,该调整将于11月2日开盘前正式生效。
标普道琼斯指数宣布,休伦咨询将接替Supernus Pharmaceuticals,成为标普小盘600指数成分股,该调整将于11月2日开盘前正式生效。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.